Vertex 2025 Calendar
BlogVertex 2025 Calendar – Vertex Pharmaceuticals is the global leader in cystic fibrosis treatment and now is expanding into other areas that could bring in billion-dollar revenue. The company expects to file for the . Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is expected to release earnings results for its fourth quarter, after the closing bell on Feb. 5, 2025. .
Vertex 2025 Calendar 2025 Calendar Templates and Images: Heading into 2025, Vertex pegged its product revenue guidance at $10.55 billion to $10.75 billion. The company expects to see continued growth in CF as well as the launch of Casgevy, its recently . (MENAFN- GlobeNewsWire – Nasdaq) KING OF PRUSSIA, Pa., Feb. 06, 2025 (GLOBE NEWSWIRE) — Vertex, Inc. (NASDAQ:VERX) (โVertexโ or theโCompanyโ), a global .